Unknown bacterial molecular target in Alphaproteobacteria

The term Unknown bacterial molecular target in Alphaproteobacteria refers to an unidentified molecular component within bacteria of the class Alphaproteobacteria that serves as the site of action for specific antimicrobial compounds. This designation is primarily used as a placeholder in pharmacological databases, such as ChEMBL, for compounds that demonstrate potent phenotypic activity against Alphaproteobacteria (including pathogens like Brucella or endosymbionts like Wolbachia) but whose specific protein or nucleic acid target has not yet been definitively characterized. A prominent example of a drug associated with this classification is the anti-Wolbachia candidate AWZ1066S, which was identified through phenotypic screening and exhibits high specificity for Wolbachia endosymbionts in filarial nematodes, although its exact molecular target remains under investigation. Other compounds, such as CBR-4830, were initially categorized under unknown targets in Alphaproteobacteria before being linked to specific proteins like MreB. Targeting these unidentified components is a critical strategy in the development of macrofilaricidal drugs for treating neglected tropical diseases such as lymphatic filariasis and onchocerciasis.

Other names

Unknown bacterial molecular targetUnidentified target in AlphaproteobacteriaWolbachia molecular target

Inhibition of bacterial growth or survival through an unidentified molecular mechanism, often involving the depletion of endosymbiotic bacteria in filarial nematodes.